Cargando…

Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysis

Circulating tumor cells (CTCs) are considered to be related to the prognosis of cancer patients. CTC is a powerful indicator for recurrence or metastasis. The relationship, however, between the expression of programmed cell death receptor ligand 1 (PD-L1) on CTCs in peripheral blood and the prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Defeng, Zhang, Wen, Yang, Zhenrong, Li, Guoliang, Cheng, Shujun, Zhang, Kaitai, Feng, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218685/ https://www.ncbi.nlm.nih.gov/pubmed/34211802 http://dx.doi.org/10.1080/2162402X.2021.1938476

Ejemplares similares

Telomerase positive CTCs with PSMA high expression associated with prostate cancer metastasis
por: Yang, Zhenrong, et al.
Publicado: (2022)

Construction and validation of a chemokine family-based signature for the prediction of prognosis and therapeutic response in colon cancer
por: Zhang, Wen, et al.
Publicado: (2023)

Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes
por: Kong, Defeng, et al.
Publicado: (2022)

Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study
por: Yang, Zhenrong, et al.
Publicado: (2022)

Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing
por: Li, Guoliang, et al.
Publicado: (2022)

SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment
por: Kong, Defeng, et al.
Publicado: (2022)

Single-cell transcriptomics of peripheral blood reveals anti-tumor systemic immunity induced by oncolytic virotherapy
por: Wu, Quanyou, et al.
Publicado: (2022)

Telomerase-positive circulating tumor cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma
por: Zhang, Wen, et al.
Publicado: (2021)

Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome
por: Polioudaki, Hara, et al.
Publicado: (2020)

Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)
por: Bergmann, Sonja, et al.
Publicado: (2020)

Combination of CT and telomerase(+) circulating tumor cells improves diagnosis of small pulmonary nodules
por: Zhang, Wen, et al.
Publicado: (2021)

Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
por: Kejík, Zdeněk, et al.
Publicado: (2021)

PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma
por: Ma, Ke, et al.
Publicado: (2017)

Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer
por: Xu, Ying, et al.
Publicado: (2023)

PD-L1 expression in lung cancer and its correlation with driver mutations: a meta-analysis
por: Zhang, Minghui, et al.
Publicado: (2017)

MiSelect R System: the validation of a new detection system of CTCs and their correlation with prognosis in non-metastatic CRC patients
por: Lin, Chun-Chi, et al.
Publicado: (2023)

Enhanced Therapeutic Efficacy of a Novel Oncolytic Herpes Simplex Virus Type 2 Encoding an Antibody Against Programmed Cell Death 1
por: Zhu, Yujie, et al.
Publicado: (2019)

PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis
por: Gu, Lihu, et al.
Publicado: (2017)

Expression of PD-L1 and prognosis in breast cancer: a meta-analysis
por: Zhang, Minghui, et al.
Publicado: (2017)

Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer
por: Liu, Xiaoyu, et al.
Publicado: (2018)

Correlation of PD-L1 and SOCS3 Co-expression with the Prognosis of Hepatocellular Carcinoma Patients
por: Chen, Liuxi, et al.
Publicado: (2020)

PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer
por: Song, Minmin, et al.
Publicado: (2013)

CTCs Expression Profiling for Advanced Breast Cancer Monitoring
por: Pereira-Veiga, Thais, et al.
Publicado: (2019)

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
por: Anantharaman, Archana, et al.
Publicado: (2016)

Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients
por: Weng, Xun, et al.
Publicado: (2022)

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs
por: Allen, Joshua E., et al.
Publicado: (2013)

CtcS, a MarR family regulator, regulates chlortetracycline biosynthesis
por: Kong, Lingxin, et al.
Publicado: (2019)

Elevated expression of lung development-related protein HSP90β indicates poor prognosis in non-small cell lung cancer through affecting the cell cycle and apoptosis
por: Wang, Xiang, et al.
Publicado: (2021)

PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC)
por: Pantazaka, Evangelia, et al.
Publicado: (2022)

ERBB signaling in CTCs of ovarian cancer and glioblastoma
por: Geethadevi, Anjali, et al.
Publicado: (2017)

CTCs 2020: Great Expectations or Unreasonable Dreams
por: Rossi, Elisabetta, et al.
Publicado: (2019)

High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Lin, Yueh-Min, et al.
Publicado: (2015)

PD-L1 is associated with the prognosis of penile cancer: A systematic review and meta-analysis
por: Lu, Yi, et al.
Publicado: (2022)

Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases
por: Mamdouhi, Tania, et al.
Publicado: (2019)

Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis
por: Tucci, Marco, et al.
Publicado: (2020)

Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer
por: Zhang, Qianqian, et al.
Publicado: (2021)

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis
por: Zhu, Hao‐Hua, et al.
Publicado: (2021)

Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients
por: Katsarou, Spyridoula D., et al.
Publicado: (2022)

Proliferation genes in lung development associated with the prognosis of lung adenocarcinoma but not squamous cell carcinoma
por: Li, Ping, et al.
Publicado: (2017)

Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements
por: Kallergi, G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_869nukh0eqb3nc99s2jh3pblk8